Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
154229-19-3
Purity
95%
Abiraterone is an orally active inhibitor of the steroidal enzyme CYP17A1. Abiraterone is a derivative of steroidal progesterone and is an innovative drug that offers clinical benefit to patients with hormone refractory prostate cancer. It is used in combination with prednisone for the treatment of metastatic, castration-resistant prostate cancer.
Properties
Name
Abiraterone
Smiles
C[C@@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]2CC=C1C=5C=CC=NC5
Targets
Please log in to see this information
SDS
(3β)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol | 17-(3-pyridinyl)androsta-5,16-diene-3β-ol | 17-(3-pyridyl)androsta-5,16-dien-3β-ol | 3'-(3β-hydroxyandrosta-5,16-dien-17-yl)pyridine | ABT | Abi | CB-7598 | abiraterone | abiraterone acetate
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
(3β)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol | 17-(3-pyridinyl)androsta-5,16-diene-3β-ol | 17-(3-pyridyl)androsta-5,16-dien-3β-ol | 3'-(3β-hydroxyandrosta-5,16-dien-17-yl)pyridine | ABT | Abi | CB-7598 | abiraterone | abiraterone acetate
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.